These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 2350702

  • 1. MPTP-induced parkinsonism: relative changes in dopamine concentration in subregions of substantia nigra, ventral tegmental area and retrorubral field of symptomatic and asymptomatic vervet monkeys.
    Elsworth JD, Deutch AY, Redmond DE, Sladek JR, Roth RH.
    Brain Res; 1990 Apr 16; 513(2):320-4. PubMed ID: 2350702
    [Abstract] [Full Text] [Related]

  • 2. The neurotoxin MPTP does not reproduce in the rhesus monkey the interregional pattern of striatal dopamine loss typical of human idiopathic Parkinson's disease.
    Pifl C, Schingnitz G, Hornykiewicz O.
    Neurosci Lett; 1988 Oct 05; 92(2):228-33. PubMed ID: 3263594
    [Abstract] [Full Text] [Related]

  • 3. Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP.
    Schneider JS, Yuwiler A, Markham CH.
    Brain Res; 1987 May 12; 411(1):144-50. PubMed ID: 2886180
    [Abstract] [Full Text] [Related]

  • 4. Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells.
    German DC, Manaye KF, Sonsalla PK, Brooks BA.
    Ann N Y Acad Sci; 1992 May 11; 648():42-62. PubMed ID: 1353337
    [Abstract] [Full Text] [Related]

  • 5. Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment.
    Elsworth JD, Taylor JR, Sladek JR, Collier TJ, Redmond DE, Roth RH.
    Neuroscience; 2000 May 11; 95(2):399-408. PubMed ID: 10658619
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differential effects of acute and chronic nicotine treatment on MPTP-(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced degeneration of nigrostriatal dopamine neurons in the black mouse.
    Janson AM, Fuxe K, Goldstein M.
    Clin Investig; 1992 May 11; 70(3-4):232-8. PubMed ID: 1521037
    [Abstract] [Full Text] [Related]

  • 14. Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?
    Herrero MT, Hirsch EC, Kastner A, Ruberg M, Luquin MR, Laguna J, Javoy-Agid F, Obeso JA, Agid Y.
    Neuroscience; 1993 Sep 11; 56(2):499-511. PubMed ID: 8247275
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Intrastriatal implantation of interleukin-1. Reduction of parkinsonism in rats by enhancing neuronal sprouting from residual dopaminergic neurons in the ventral tegmental area of the midbrain.
    Wang J, Bankiewicz KS, Plunkett RJ, Oldfield EH.
    J Neurosurg; 1994 Mar 11; 80(3):484-90. PubMed ID: 7906726
    [Abstract] [Full Text] [Related]

  • 18. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF.
    Elsworth JD, Deutch AY, Redmond DE, Sladek JR, Roth RH.
    Brain Res; 1987 Jul 14; 415(2):293-9. PubMed ID: 3496938
    [Abstract] [Full Text] [Related]

  • 19. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey.
    Pifl C, Schingnitz G, Hornykiewicz O.
    Neuroscience; 1991 Jul 14; 44(3):591-605. PubMed ID: 1754053
    [Abstract] [Full Text] [Related]

  • 20. Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys: behavioural, morphological and biochemical correlates.
    Albanese A, Granata R, Gregori B, Piccardi MP, Colosimo C, Tonali P.
    Neuroscience; 1993 Aug 14; 55(3):823-32. PubMed ID: 8105418
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.